Abstract | OBJECTIVE: METHOD: Serum type I IFN activity was measured in 33 consecutive patients with SSc and a disease duration of < 2 years and in 13 healthy individuals by calculating a type I IFN score according to the induction of six IFN-α regulated genes in a reporter cell line. RESULTS: Twenty-seven per cent of the SSc patients had an increased type I IFN score compared to none of the healthy individuals (p < 0.05). The clinical SSc phenotype associated with high serum type I IFN activity did not differ from patients with low serum type I IFN activity regarding the presence of skin or lung fibrosis, pulmonary hypertension, or digital complications. Patients with high serum type I IFN activity were younger (p < 0.01) and had a lower frequency of cardiac involvement (p = 0.053), lower leucocyte count (p < 0.001), higher immunoglobulin (Ig)G levels (p < 0.05), and a higher amount of antibodies against extractable nuclear antigens (p < 0.01) than patients with low serum type I IFN activity. The presence of antibodies against topoisomerase I, Sjögren's syndrome antigen, and nuclear ribonucleoprotein antigens was associated with higher type I IFN activity (p < 0.05 for all comparisons). CONCLUSIONS: Our study indicates that increased serum type I IFN activity in early SSc patients is associated with an antibody and laboratory profile that may reflect a subclinical overlap of SSc with other type I IFN-driven connective tissue diseases ( CTDs).
|
Authors | D M Wuttge, C Lood, E Tufvesson, A Scheja, L Truedsson, A A Bengtsson, R Hesselstrand |
Journal | Scandinavian journal of rheumatology
(Scand J Rheumatol)
Vol. 42
Issue 3
Pg. 235-40
( 2013)
ISSN: 1502-7732 [Electronic] England |
PMID | 23379597
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Autoantibodies
- Interferon Type I
- Ribonucleoproteins
|
Topics |
- Adult
- Aged
- Autoantibodies
(blood)
- Case-Control Studies
- Female
- Humans
- Interferon Type I
(blood)
- Male
- Middle Aged
- Ribonucleoproteins
(immunology)
- Scleroderma, Systemic
(blood, immunology)
- Sjogren's Syndrome
(immunology)
|